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  CD4/CD8 T cell lineage commitment is one of the central issues in the 
development of the immune system. T cell receptor (TCR) signal strength 
and/or duration is known to be a key in determining the lineages. Several 
transcription factors are known to participate during CD4/CD8 lineage 
commitment. Gata3 and ThPOK reportedly play critical roles in CD4 single-
positive (CD4 SP) differentiation. Conversely, Runx3 and Mazr reportedly 
play important roles in CD8 single-positive (CD8 SP) differentiation. 
Particularly, ThPOK seems to be both necessary and sufficient for 
CD4-lineage differentiation and Runx3 plays an important role in CD8 SP 
differentiation by repressing ThPOK expression. However, the critical factor(s) 
regulating this process is still missing. For example, a defined factor(s) 
translating the TCR signal and co-receptor complexes into the lineage 
differentiation is not clear yet. Also, it has been reported that the Runx 
complex binds persistently to the silencer region of ThPOK in thymocyte 
subsets, regardless of their capability to differentiate into the CD4 or CD8 SP 
lineage. Thus, it has been postulated that some other factor(s) would act to 
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resolve the distinct suppressive activity of the Runx complex on ThPOK 
between CD4 and CD8 SP cells.  
  Twist2 is a basic helix-loop-helix transcription factor that generally act as 
transcriptional repressors. It was reported that Twist2 expression was found to 
be regulated by TCR signaling and to adjust the survival or death of 
thymocytes and Twist2 controls TCR-mediated apoptosis by regulating the 
expression of Nur77 and Nor-1. These results suggest that Twist2 may play an 
important role during lymphocyte development. 
  Here, I show that Twist2 is a critical factor for CD4/CD8 thymocyte 
differentiation. Twist2 expression is differentially regulated by T-cell receptor 
signaling leading to differentiation into the CD4 or CD8 lineage. Twist2 
expression was higher in CD8 SP thymocytes than in CD4 SP thymocytes. 
Twist2 interacts with Runx3 and their interaction is dependent on Twist2 
carboxyl-terminal Twist-box. Also, Twist2 downregulated the expression of 
ThPOK like Runx3. Twist2 could bind to the silencer region of the ThPOK 
promoter in a lineage-dependent manner. ThPOK silencer has two important 
regions, which are an essential 80bp core sequence (containing NFkb and E 
box) and a Runx binding domain. Twist2 was specifically bound to the Runx 
sites. These results suggest that Twist2 interacts with Runx3 to bind to the 
RBS1 site of ThPOK, thereby blocking its expression. Moreover, Twist2 
transgenic mice perturbed CD4+ thymocyte differentiation, whereas enhanced 
CD8+ thymocyte differentiation. In contrast, the development of CD8 SP 
thymocytes was impaired in Twist2 deficient mice. Also, Twist2 expression 
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produced mature CD8+ thymocytes in B2m-/- mice, while its deficiency 
significantly impaired CD8+ cells in TCR transgenic mice favoring CD8 T-
cell differentiation. These gain-of-function and loss-of-function mutations 
mice systems showed that Twist2 has a critical role in CD4/CD8 thymocyte 
lineage differentiation through interaction with Runx complex to suppress the 
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I. Thymocyte differentiation  
 
Bone marrow-derived progenitors for T cells expressing T cell receptors 
(TCRs) develop in the thymus through stages that are characterized by the 
expression of CD4 and CD8 co-receptors(Rothenberg and Taghon, 2005; von 
Boehmer, 2004). The earliest progenitors do not express either CD4 or CD8 
(double negative; DN). DN thymocytes can be further subdivided into four 
stages based on the surface expression of CD44 and CD25 molecules: 
CD44+CD25-(DN1), CD44+CD25+(DN2), CD44-CD25+(DN3), and CD44-
CD25-(DN4)(Ceredig and Rolink, 2002). TCR β-chain gene rearrangement 
occurs during DN3 stage. After successful TCR β-chain gene rearrangement, 
DN3 thymocytes further differentiate into the DN4 (CD44-CD25-) stage, 
followed by the intermediate single-positive (ISP) and CD4+CD8+ double-
positive (DP) stages. DP thymocytes go through positive and negative selection 
depending on the interaction of their TCRs with the major histocompatibility 
complex (MHC) expressed on thymic stromal cells(Doyle and Strominger, 
1987; Norment et al., 1988). Only a small fraction of DP thymocytes can 
differentiate into CD4 single-positive (CD4 SP) or CD8 single-positive (CD8 
SP) cells.  
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The lineage decision of DP thymocytes between CD4 SP and CD8 SP has 
been investigated intensively(Bosselut, 2004; Kappes et al., 2005; Laky and 
Fowlkes, 2005; Seong et al., 1992; Singer and Bosselut, 2004). Although 
several models have been proposed, it is generally well accepted that the match 
between MHC classes and the TCR with a CD4 or CD8 co-receptor is critical 
for differentiation. MHC class II-selected thymocytes differentiate into CD4 SP 
committed to the helper lineage, whereas thymocytes expressing MHC class I–
restricted TCRs differentiate into CD8 SP thymocytes committed to the 
cytotoxic lineage. TCR signaling from the CD4 co-receptor was shown to be 
stronger than that from the CD8 co-receptor, and Lck tyrosine kinase was 
suggested to play an important role during this signal transduction(Hernandez-
Hoyos et al., 2000; Lovatt et al., 2006). The high kinase activity of Lck 
redirects MHC class I-restricted thymocytes into the CD4 SP thymocyte 
lineage, whereas low kinase activity generates MHC class II-restricted CD8 SP 
thymocytes. These results suggest that kinase activity near proximal TCR 
signaling is critical for CD4/CD8 lineage commitment. In addition, the kinetic 
modulation of CD4 and CD8 co-receptors has been proposed to be important 
for differentiation(Singer, 2002). Thus, it appears that signal transduction from 
TCR is critical for CD4/CD8 lineage differentiation. 
 
II. Transcription factor in lineage commitment 
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Some transcription factors may link proximal TCR signaling to the 
CD4/CD8 lineage commitment process(He et al., 2005; Hernandez-Hoyos et 
al., 2003; Sun et al., 2005a; Wilkinson et al., 2002; Woolf et al., 2003). Tox is 
essential for the transition from positively selected thymocytes to the 
CD4+CD8lo stage where lineage commitment may be determined and 
maintaining or upregulating CD4 expression in positively selected DP 
thymocyte(Aliahmad and Kaye, 2008; Aliahmad et al., 2004). In TOX 
deficient mice, positively selected thymocytes do not differentiate into 
CD4+CD8lo cells but instead become CD4loCD8lo cells that fail to develop into 
CD4 SP cells, whereas CD8 SP T cell development is almost normal 
(Aliahmad and Kaye, 2008). Gata3 and ThPOK (T-helper-inducing 
POZ/Kruppel- like factor; also known as Zbtb7b or cKrox; called “ThPOK” 
hereafter) reportedly play critical roles in CD4 SP differentiation. GATA3 is 
induced by TCR signaling in DP cells(Hernandez-Hoyos et al., 2003) and 
preferentially expressed by CD4+ T cells(Hendriks et al., 1999). In addition, 
Gata3 overexpression blocks the generation of CD8 SP cells (Nawijn et al., 
2001; Pai et al., 2003), whereas Gata3 deficiency severely decreased CD4 SP 
cell numbers without affecting CD8 SP generation(Pai et al., 2003). However, 
GATA3 overexpression does not redirect MHC class I-restricted thymocytes 
into the CD4 SP cells, which indicated that GATA3 is not a CD4 lineage 
specifying factor(Hernandez-Hoyos et al., 2003). ThPOK deficiency or a 
mutation in the ThPOK gene results in the complete perturbation of CD4 SP 
development and redirection of MHC class II-signalled thymocytes to the CD8 
SP cell, whereas ThPOK overexpression in the thymus redirects MHC class I-
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restricted thymocytes to the CD4 SP thymocyte lineage(Dave et al., 1998; He 
et al., 2005; Sun et al., 2005a). Conversely, Runx3 and Mazr reportedly play 
important roles in CD8 SP differentiation. Runx3 can suppress both CD4 co- 
receptor and ThPOK expression by directly binding to the silencer region of 
both genes(Setoguchi et al., 2008; Taniuchi et al., 2002).  Runx1 and Runx3 
double deficient mice impair CD8 SP development, whereas T cell specific 
Runx3 transgenic mice increase the proportion of CD8 SP thymocytes(Grueter 
et al., 2005; Kohu et al., 2005; Woolf et al., 2003). Also, Mazr represses 
ThPOK expression in MHC class I–signaled DP thymocytes via binding to the 
ThPOK silencer and thus prevents redirection of CD8 SP cells into the CD4 




The transcription factor ThPOK is a zinc-finger protein that is encoded by 
the Zbtb7b (also known as Zfp67) gene. Two laboratories first discovered that 
ThPOK is important for CD4 lineage differentiation(He et al., 2005; Sun et al., 
2005a). One of them used cDNA microarray tool to compare mRNA 
expression in intrathymically TCR signaled thymocytes (CD69+ DP cells) and 
CD69- unsignaled DP thymocytes(Sun et al., 2005a). Excluding a number of 
molecules that had been previously published, one of the most highly 
upregulated genes was Zfp67. They also found ThPOK expression was greater 














Figure 1. Overview of TCR signal cues and transcription factors that 





















impaired and MHC class I-restricted thymocytes differentiated into CD4+ T 
cells with helper properties in ThPOK transgenic mice.  Another team 
identified a spontaneous recessive mutation in mice, the HD (helper deficient) 
mutation. This mutation caused redirection of MHC class-II-signaled 
thymocytes to the CD8 SP lineage whereas no detectable TCR signalling 
defects in HD mice(Keefe et al., 1999). They identified a point mutation which 
A to G change at 1165 position within the ThPOK coding region, resulting in 
an Arg to Gly change at amino acid position 389(He et al., 2005). This 
mutation caused mutation in the second zinc finger domain of ThPOK and 
presumably disrupts DNA binding. According to results of two laboratories, 
ThPOK seems to be both necessary and sufficient for CD4-lineage 
differentiation(Kappes et al., 2006).  
ThPOK is essential to maintain CD4 T cell integrity in peripheral CD4+ T 
cells. Cytotoxic effector gene, perforin, Granzyme B and Eomes, elevated in 
ThPOK reduced peripheral CD4+ T cells. However, enforced expression of 
ThPOK in peripheral CD8+ T cells induces CD4+ T cell lineage 
features(Jenkinson et al., 2007). Also, it was reported that ThPOK maintains 
Cd4 gene transcription by antagonizing silencer activity through binding to 
CD4 silnencer region(Muroi et al., 2008), whereas it decreases Cd8 gene 




IV. Regulatory region of ThPOK gene locus  
 
Two laboratories identified potential cis-acting elements within the ThPOK 
fragment(He et al., 2008; Setoguchi et al., 2008). He et al. (2008) performed 
DNase I Hypersensitive Site (DHS) analysis and transgenic reporter assays. 
They found six DHS sites. Among them, distal regulatory element (DRE) acts 
as a repressor and general T lymphoid element (GTE) and proximal regulatory 
element (PRE) act positive regulatory elements of ThPOK. Especially, DRE is 
important site for suppression of ThPOK expression in MHC class I-restricted 
thymocytes, because the deletion of DRE resulted in reporter expression in 
both the CD4 and CD8 lineages. In addition, deletion and mutagenesis analysis 
defined an essential 80bp core sequence of DRE. The 80 bp core region is 
essential for silencer function and contains both an NFkB and E-box motif. 
They suggest the model that ThPOK transcription is repressed by a DRE-
dependent mechanism at the DP stage and CD8 SP stage, and MHC class II-
TCR signaling converts the DRE from silencer to enhancer mode and initiates 
ThPOK transcription at the CD4+8lo stage. In CD4 SP cells, ThPOK expression 
is maintained by a TCR independent mechanism and maybe required the GTE 
and PRE elements(He et al., 2008).  
Setoguchi et al. (2008) identified two major cis-regulatory elements of 
ThPOK using transgenic reporter assay and ChIP-on-chip experiments. To 
understand mechanisms of Runx-mediated ThPOK repression, they performed 
ChIP-on-chip experiment whether Runx complexes directly bind to the ThPOK 
locus, and then identified two binding regions of Runx complexes in the 
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ThPOK locus. Distal Runx-binding sequences (RBS1) and proximal Runx-
binding sequences (RBS2) are located ~3.1 kb upstream and ~7.4 kb 
downstream of exon Ia. To understand the function of RBS1 and RBS2, they 
performed transgenic reporter assays, identifying RBS1 (also called ThPOK 
silencer) acts as a transcriptional silencer and RBS2 (also called Proximal 
enhancer) acts as an enhancer. RBS1 domain overlaps DRE region. To identify 
the physiological function of the RBS1, they produced RBS1- or RBS2- 
deleted mice. Deletion of RBS1 from one ThPOK allele resulted in the loss of 
peripheral CD8+ T cells and derepression of ThPOK in CD69– DP thymocytes. 
Thus, they concluded that Runx-dependent silencer activity inhibits ThPOK 
expression and CD4+ T cell development, resulting in cytotoxic T cell 
differentiation. Deletion of the RBS2 lead to inefficient upregulation of 
ThPOK, resulting in the transdifferentiation of helper lineage cells into the 
cytotoxic T cell lineage. However, Runx complexes always bind to RBS-1 and 
RBS-2 in both ThPOK–expressing and nonexpressing cells, so Runx binding to 
these regions did not correlate with ThPOK repression. Therefore, they suggest 
that additional molecules that interact with Runx complex bound to the ThPOK 
silencer may play a central role in ThPOK silencer activity(Setoguchi et al., 
2008). 
In addition, GATA3 induce ThPOK expression via binding to at least two 
sites within the ThPOK locus (Site A and SiteB)(Wang et al., 2008). Site A 
domain overlaps RBS2 region. Also, Recent studies reported that transcription 























Figure 2. Regulatory regions of ThPOK gene locus. 
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lineage differentiation(Sakaguchi et al., 2010). (Figure 2 shows a schematic 
diagram of regulatory regions for ThPOK locus.) 
 
V. Runx complex 
  
Runx proteins contain a conserved 128 amino acid Runt DNA binding 
domain. Three mammalian Runt domain transcription factors have been 
identified, that is Runx1, Runx2, and Runx3(Levanon and Groner, 2004). Runx 
transcription factors are heterodimers from one of the three Runx proteins with 
a non–DNA-binding partner, Cbfb protein(Ito, 1999). Also, Runx proteins 
contain conserved Val-Trp-Arg-Pro-Tyr (VWRPY) motif that recruit the 
Groucho/TLE co-repressor proteins to their target genes(Aronson et al., 1997; 
Levanon et al., 1998). In the thymus, Runx1 is mainly expressed in DN 
thymocytes and is required to repress CD4 expression(Taniuchi et al., 2002). 
Runx3 is not expressed in pre-selected DP cells and its expression is induced 
by IL-7 cytokine signals during the differentiation of CD4+CD8lo thymocytes 
into CD8 SP cells(Liu et al., 2005; Park et al., 2010). Runx1 and Runx3 can 
bind to the Cd4 silencer region to suppress the Cd4 gene expression(Taniuchi 
et al., 2002; Woolf et al., 2003) and bind to the E8I Cd8 enhancer element to 
reinitiates Cd8 expression(Sato et al., 2005). Also, recently, Runx complex was 
found to bind to silencer and enhancer regions of ThPOK(Setoguchi et al., 
2008). Thus, Runx complex promotes CD8 SP differentiation through silencing 




Myc-associated ZF-related factor (MAZR; also known as Patz1 or Zfp278 
and encoded by the Patz1 gene) is member of the family of zinc-finger factors 
that contain a BTB (POZ) domain(Bilic and Ellmeier, 2007). MAZR binds to 
several Cd8 cis-regulatory elements and acts as one of the factors involved in 
keeping the Cd8 loci in a transcriptional off state in DN thymocytes(Bilic et al., 
2006).  
MAZR interacts with Runx proteins through C-terminal ZF7 domain. In 
preselected DP thymocytes, MAZR and Runx1 together repressed ThPOK, 
whereas in CD8+ T cells, MAZR and Runx3 synergized suppression of ThPOK 
expression. MAZR is also required for the maintenance of ThPOK repression 
in peripheral CD8+ T cells(Sakaguchi et al., 2010). Also, Runx1-MAZR and 
Runx3-MAZR double knock out mice showed that increased Cd4 derepression 
in DN and in CD8 SP, respectively(Sakaguchi et al., 2015). Therefore, this is 
indicated that synergistic activities between Runx complexes and MAZR could 





Twist2 is a class II basic helix-loop-helix transcription factor that was 
discovered in Drosophila as an E12 binding protein(Li et al., 1995). There are 
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two murine homologs of Drosophila Twist: Twist1 and Twist2(Sosic et al., 
2003). Twist2 dimerizes with class I bHLH proteins like E proteins, then binds 
to E box domains. Murine Twist proteins generally act as transcriptional 
repressors. Also, Twist2 expression is related to the mesenchymal cell lineage 
such as osteoblast, myocytes, and adipocytes and Twist2 involved in early 
embryogenesis, bone, muscle, and adipocyte differentiation, and epithelial-
mesenchymal transition(Li et al., 1995). For example, Twist2 inhibits the 
osteoblast differentiation in preosteoblast(Tamura and Noda, 1999) and 
represses the transcriptional activity of MEF-MyoD during myogenesis(Gong 
and Li, 2002). Also, Twist2 is highly expressed in fat tissue and inhibits 
transcriptional activity of ADD1/SREBP1c, so involves in adipocyte 
differentiation(Lee et al., 2003). These studies show that Twist2 plays an 
important role in lineage differentiation of various tissues. 
Twist2-deficient mice show growth retardation and perinatal death due to 
cachexia(Sosic et al., 2003). Twist2 knock out mice show increased apoptotic 
bodies in the thymus and spleen and also increased cytokine production, 
proinflammatory gene expression and myeloid lineage differentiation(Sharabi 
et al., 2008; Sosic et al., 2003). Twist2 binds to cytokine promoters and inhibits 
their activity. Recently, Twist2 expression was found to be regulated by TCR 
signaling and to adjust the survival or death of thymocytes. Twist2 expression 
is induced via the Ca2+–Cacineurin–NFATc3 pathway through moderate TCR 
signal of positive selection, whereas NFATc3-dependent Twist2 expression is 
abolished via specific activation of the JNK pathway through strong TCR 
signal of negative selection(Oh et al., 2016). Also Twist2 controls TCR-
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mediated apoptosis by regulating the expression of Nur77 and Nor-1(Oh et al., 
2016). These results suggest that Twist2 may play an important role during 
lymphocyte development. Here, I show that Twist2 is a critical player during 









Twist2 transgenic mice and Twist2 conditional knockout mice were raised 
in our laboratory and have been described(Oh et al., 2016). ThPOK-GFP 
mice(Setoguchi et al., 2008) were from Ichiro Taniuchi; CD4 transgenic 
mice(Van Laethem et al., 2007) were from Alfred Singer; and Runx3 
transgenic mice(Kohu et al., 2005) were provided by Masanobu Satake. Rag-/- 
HY-TCR and Rag-/- DO transgenic mice were purchased from Taconic Farms 
(Korea). Tcra-/- mice and B2m-/- mice were obtained from the Jackson 
Laboratory. C57BL/6 mice were purchased from Charles River Laboratories. 
The mice were routinely screened by PCR with DNA obtained from tail tissue. 
Mice between 4-8 weeks old were used for experiments. The mice were bred 
and maintained under specific pathogen-free conditions, and experiments were 
performed in accordance with institutional and national guidelines.  
 
Cell culture and transient transfection 
 
293T cells and HeLa cells were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM, WelGENE) supplemented with 10% FBS (WelGENE), 
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100U/ml streptomycin and penicillin.  Twist2 and/or Runx3-expressing vector 
was transient transfected into 293T cells by Calcium phosphate transfection 
method following the manufacturer’s instruction. 
 
Bone marrow reconstitution assay  
 
Bone marrow cells from lck-Cre Twist2+/+ or lck-Cre Twist2f/f mice 
(CD45.2+) were labeled with biotinylated anti-CD3ε (145-2C11; BD 
Bioscience), followed by negative depletion with anti-biotin bead (Miltenyi 
Biotec). T cell-depleted bone marrow cells were mixed at a ratio of 1:1 with T-
cell depleted CD45.1+ bone marrow cells, and 8 ×106 cells were injected in to 
the tail veins of lethally irradiated 8 week old MHC class II-/- mice (5.5Gy x 2; 
137Cs source, NCIRF). At 4 weeks after transplantation, mice were sacrificed 




PerCP-conjugated streptavidin, anti-CD3ε-PE, anti-CD4-PE, anti-CD4-
PE-Cy7, anti-CD8-FITC, anti-CD8-APC-Cy7, anti-CD69-PerCP, anti-TCRβ-
APC, anti-CD44-FITC, anti-CD25-APC, anti-CD24-PE-Cy7, anti-HY-TCR-
APC, and anti-DO11.10-PerCPcy5.5 antibodies were purchased from BD 
Biosciences or eBioscience. Anti-Twist2 monoclonal antibody (H00117581-





Single cell suspensions were prepared from thymus, spleen, and lymph 
node and then passed through cell straniner to remove cell debris. The red 
blood cells were lysed by ACK lysis buffer (155mM NH4Cl, 10mM KHCO3, 
and 0.1mM EDTA). 3 x 106 cells were used for antibody staining. Stained cells 
were analyzed or collected on a FACSCanto II or a FACSAria II (BD 
Biosciences). For cell sorting, a single-cell suspension of thymocytes was 
stained using anti-CD4-PE, anti-CD8-APC-Cy7, anti-TCRβ-APC, anti-CD24-
PE-Cy7 and anti-CD69-PerCP antibodies, and each subset of cells was sorted. 
The purity of all sorted populations was above 95%. 
 
RT-PCR and Q-PCR 
  
RNA was extracted from the sorted populations or tissues by Trizol 
reagent (Invitrogen) according to the manufacturer’s instruction. RNA was 
reverse transcribed with SuperScript III (Invitrogen) or QuantiTect Reverse 
Transcription Kit (Qiagen). Semi-quantitative RT-PCR was conducted by 
using a PCR premix kit (ELPIS Biotech, Korea). Quantitative RT-PCR was 
conducted with Taqman Master mix (Applied Biosystems) and primers 
purchased from Assays-On-Demand (Applied Biosystems) for Twist2, ThPOK, 
! 17!
Runx3 and GAPDH. The results were quantified with StepOnePlus® (Applied 
Biosystems). GAPDH was used as an internal control for RT-PCR analysis. 
 
Co-immunoprecipitation and western blotting 
 
Myc-tagged Runx3 and/or HA-tagged Twist2 was transfected into 293T 
cells. Cells were lysed with IPLS lysis buffer (0.05 M Tris-Cl pH 7.5, 150 mM 
NaCl, 0.5 mM EDTA, and 0.5% NP-40) supplemented with protease inhibitor 
cocktail (Roche). Cell lysates were immunoprecipitated with anti-Myc 
antibodies. Proteins were separated by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis and transferred to Immobilon-P membrane (Millipore). 
Blotted proteins were detected using antibodies to Twist2 (H00117581-M01, 
Abnova), Myc epitope (9E10, Roche), and HA epitope (HA-7, Sigma) with 5%  
skim milk in TBST (150mM NaCl, 10mM Tris-Cl, pH8.0, 0.5% Tween-20). 
Protein bands were visualized by chemiluminescence using Enhanced 




Total 106 thymocytes were fixed with 1% formaldehyde for 10 min at 
37°C. Cells were collected by centrifugation and washed twice in cold PBS 
containing protease inhibitors (1mM PMSF and protease inhibitor cocktail, 
! 18!
Roche) and lysed on ice for 10 min in 200µl of SDS lysis buffer (Upstate 
Biotechnology). The chromatin was sheared with an Ultrasonic processor XL 
(Misonix Inc.). The chromatin fragments are 400–600 base pairs in length. 
After adding 10 fold ChIP dilution buffer, to reduce nonspecific background, 
sonicated cell supernatants were precleared for 1h with salmon-sperm 
DNA/protein G Sepharose beads and then immunoprecipitated with anti-
Twist2 (H00117581-M01, Abnova) or control mouse IgG1 purified antibodies 
(Invitrogen, MG100) overnight at 4°C. Immunoprecipitated complexes were 
collected on salmon-sperm DNA/protein G Sepharose beads for 1h, washed 
sequentially once with low salt buffer, high salt buffer, LiCl buffer and twice 
with TE buffer and then eluted with elution buffer. Elution sample incubated 
for 4h at 65°C with 5M NaCl and then for 1h at 45°C with proteinase K to 
reverse the crosslink. DNA was purified by QiAquick Spin Kit (Qiagen) and 
eluted DNA was analyzed by PCR with the following primers: RBS1, forward: 
5'-CAG AAT AGG CGC GCA GTT A-3' and reverse: 5'-CTG GCT GGT 
CCA AGT ACA CA-3', RBS2, forward: 5'-CTA AAG AGC TGT GTG CTA 
GAC C-3' and reverse: 5'-GTT TCA GGC AGG TGA GGT TC-3', UP1, 
forward: 5'-TGT TTA GTT TGG CTT GAG CCC-3' and reverse: 5'-CCC TCC 
TAC TCG TTT CAA AC-3' and GAPDH intron, forward: 5’-TTA CTT TCG 




Duolink in situ PLA analysis  
 
Transfected HeLa cells or sorted thymocytes were used. The cells were 
fixed with 4% paraformaldehyde for 20 min, permiablized with 0.1% Triton X-
100 for 5 min and then blocked with Duolink blocking buffer (Olink 
Bioscience) for 30 min at 37°C. The permeabilized HeLa cells/thymocytes 
were incubated with antibodies against Myc and HA/Twist2 (H00117581-M01; 
Abnova) and CBFβ (ab33516; Abcam) overnight at 4°C. For secondary 
antibodies, PLA probes conjugated with a unique short DNA strand (anti-rabbit 
PLUS and anti-mouse MINUS; Olink Bioscience) were added and incubated 
for 1h at 37°C. After ligation and circularization of the DNA, they were 
amplified via rolling circle amplification using polymerase for 1h at 37°C and 
the reactions were detected using a complementary Cy3-labeled DNA linker. 
The fluorescence signal was detected using confocal microscopy. 
 
Biotinylated-DNA pull-down assay 
 
Four oligonucleotides, containing biotin on the nucleotide at 5’-position, 
were used in the pull-down assays. The sequences of these oligonucleotides 
were as follows: Runx binding site (34mer) F: biotin-5’-GGG GCT GCG GTC 
TGA GCG CCC CCA GCG GTT TCC T-3’; NF-κB and E box (43mer) F: 
biotin-5’-GGA GGG GGT ACC CTT GGC AGC CAC CGC CTC TTC AGG 
TGG G TTG-3’; mut Runx binding site (34mer) F: biotin-5’-GGG GCG AAT 
! 20!
TCC TGA GCG CCC CCG AAT TCT TCC T-3’; mut NF-κB and E box 
(43mer) F: biotin-5’-GGA GGT TCT ACC CTT GGC AGC CAC CGC CTC 
TTT AGG TAG GTT G-3’. Each 2µg of double-stranded oligonucleotide was 
incubated with 100µg of nuclear proteins for 20 min at room temperature in a 
binding buffer containing 20% glycerol, 5mM MgCl2, 50mM Tris (pH 7.5), 
250mM NaCl, 2.5mM EDTA, and 10µg of poly(dI-dC) competitor. After 
incubation, 20ul of streptavidin-coated magnetic beads M-270 (Dynal®, 
Invitrogen) were added to the reaction and incubated at 4°C for 4h. The 
protein-DNA-streptavidin magnetic bead complex was washed three times with 
binding buffer and loaded onto a SDS gel. Bounding proteins in the pull-down 
material were analyzed by Western hybridization using antibodies recognizing 
HA and Myc-tag. Protein bands were visualized by chemiluminescence using 





Thymocytes stained on CD4, CD8, TCRβ, CD24 and CD69 were fixed and 
permeabilized and further stained with IgG or anti- Twist2 antibodies using the 
Foxp3 Fix/Perm Kit (eBioscience) following the manufacturer’s instruction.  
After sequential addition of the anti-mouse IgG-biotin and Streptoavidin-FITC 





Statistical analysis was performed by Prism software (GraphPad). Two-tailed 
Student’s t-tests were used to calculate p values. P values <0.05 were 






Twist2 expression is induced by TCR signaling and is more marked 
in CD8 SP induced signal  
 
To study the role of Twist2 in thymocyte differentiation, thymocytes at 
various developmental stages were sorted by flow cytometry, and Twist2 
expression was analyzed by quantitative real-time reverse transcription 
polymerase chain reaction (Q-PCR) analysis. After the DP stage, Twist2 
expression was increased at the CD4+CD8lo (CD4+CD8loCD69hiTCRβ+; 
simplified “CD4+CD8lo” hereafter) stage, followed by distinct patterns of CD4 
SP and CD8 SP thymocytes. Twist2 expression in CD8 SP thymocytes was 
approximately 3 fold higher than in CD4 SP thymocytes (Figure 3). To 
investigate whether such differential expression of Twist2 is reflected during 
CD4- or CD8-SP favored differentiation, thymocytes from Tcra-/- mice were 
activated with 0.2 ng/mL PMA and 0.2 µg/mL ionomycin (conditions leading 
to CD4 SP) or 0.1 ng/mL PMA and 0.2 µg/mL ionomycin (conditions leading 
to CD8 SP) as described previously(Wilkinson et al., 2002), and Twist2 
expression was determined by Q-PCR. Twist2 expression was induced in 
cultured DP thymocytes activated under conditions that gave rise to either CD4 
or CD8 SP cells(Shao et al., 1999; Wilkinson et al., 2002). The induced 





Figure 3. Twist2 expression is increased in CD4+CD8lo and is 3 fold higher 
in CD8 SP than in CD4 SP thymocytes.  
Twist2 expression was analyzed by quantitative real-time Q-PCR in the 
indicated thymocyte subsets from C57BL/6 mice. Results are presented relative 









up to 3h under both conditions, but showed distinct patterns at the final 
evaluation time point, similar to its expression in CD4 and CD8 SP thymocytes 
(Figure 4A). Twist2 expression was similarly increased in protein level when 
activated under the condition leading to CD8 SP differentiation (Figure 4B). 
All these results suggest that Twist2 is upregulated by TCR stimuli at both 
transcriptional and translational level. 
 
Twist2 interacts with the Runx complex in a CD8 SP differentiation 
specific manner  
 
On the basis of the differential expression of Twist2 between CD4 and 
CD8 lineage cells, I investigated the possible roles of Twist2 during CD4/CD8 
thymocyte lineage commitment. It was reported that Runx3 plays an important 
role in CD8 SP differentiation by repressing ThPOK expression(Setoguchi et 
al., 2008). Also, Previous studies have reported that Runx proteins and Twist2 
interact(Pham et al., 2012; Sharabi et al., 2008; Yang et al., 2011), and I found 
that Twist2 interacts with Runx3 as shown by co-immunoprecipitation (Co-IP) 
analysis (Figure 5). I also found that Twist2 overexpression in the DP 
thymoma L7 cell line could downregulate ThPOK expression (Figure 6). It has 
been reported that Runx complexes (heterodimers of Cbfβ and Runx1 or 








Figure 4. Twist2 expression is induced by TCR signaling and the amount 
and duration of its expression is greater in CD8 SP induced signal. 
(A) Thymocytes from Tcra-/- mice were activated with 0.2 ng/mL or 0.1 ng/mL 
PMA and 0.2 µg/mL ionomycin for the indicated time periods. Twist2 
expression was determined by Q-PCR. (B) Thymocytes from Tcra-/- mice were 
activated with 0.1 ng/mL PMA and 0.2 µg/mL ionomycin for the indicated 
times. Nuclear extracts were prepared from the thymocytes. Twist2 expression 
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Figure 5. Twist2 interacts with Runx3.  
Myc-tagged Runx3 with or without HA-tagged Twist2 was transfected into 
293T cells. Protein extracts were immunoprecipitated by using anti-Myc 
antibodies. Western hybridization was conducted by using anti-Myc and anti-
HA antibodies.   
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Figure 6. Twist2 represses the expression of ThPOK and Gata3 which are 
important for differentiation of the CD4 SP lineage. 
The Twist2-expressing vector was transfected into L7 thymoma cells by 
electroporation. The expression of GAPDH, Twist2, ThPOK, and Gata3 were 
determined by semi-quantitative RT-PCR. The data is representative of at least 


























regulatory elements of the ThPOK gene(Setoguchi et al., 2008) regardless of 
the differentiation stage. RBS1 is essential for Runx complex-mediated 
suppression of ThPOK as a silencer, whereas RBS2 is known to be an enhancer. 
Interestingly, Twist2 could bind to the RBS1 region of ThPOK, but not to 
RBS2 based on a chromatin immunoprecipitation (ChIP) assay against 
chromatin-protein complexes from CD4+CD8lo thymocytes (Figures 7A and 
7B). It is to be noted that the interaction of Twist2 to the RBS1 region was 
nearly lost in CD4+CD8lo thymocytes from β2m-deficient mice, in which CD8 
SP differentiation is impaired (Figure 7C). Conversely, the interaction was 
strongly enhanced in cells from MHC class II-/- mice. Previous studies have 
reported that some important regions are located on the ThPOK silencer region 
(Figure 2). To identify where Twist2 binds, a biotinylated-DNA pull-down 
assay was performed using biotinylated oligomers corresponding to NF-κB and 
the E box region and Runx-binding region of RBS1 (Figure 8A). As a result, I 
found that Twist2 was specifically bound to the Runx-binding region, but not 
to NF-κB and the E box region (Figure 8B). To be noted is that Twist2 could 
bind to the Runx site only if both Twist2 and Runx3 were overexpressed. 
Almost no binding of Twist2 to Runx site was observed without concurrent 
expression of Runx3 (Figure 8B).  
To test which domain of Twist2 interacts with Runx complex, I performed 
Duolink analysis and Co-IP. In Duolink assay, the red fluorescence signal 














Figure 7. Twist2 binds to the RBS1 region of ThPOK, but not to RBS2. 
(A) ChIP assay was conducted with total thymocytes from Twist2 transgenic 
mice. Q-PCR analysis was conducted against RBS1, RBS2 and UP1 regions. 
(B) ChIP assay was conducted with total thymocytes from C57BL/6 wild-type 
mice. PCR analysis was conducted against the RBS1, RBS2, and Gapdh intron 
(negative control) region of ThPOK. (C) CD4+CD8lo thymocytes were sorted 
from the indicated mice by flow cytometry, followed by ChIP with anti-Twist2 
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Figure 8. Twist2 specifically binds to the Runx sites. 
(A) Schematic diagram of position of cis-elements and oligomers used for 
biotinylated-DNA pull-down assay. (B) Biotinylated-DNA pull-down assay 
was conducted with biotinylated oligonucleotides, nuclear extracts from 293T 
cells transfected with HA-Twist2 and myc-Runx3 expressing vectors (upper 
panel) or only HA-Twist2 expressing vector as a negative control (lower panel), 
and streptavidin-coated magnetic beads. Pull-downed proteins were analyzed 
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Figure 9. The interaction between Twist2 and Runx3 is dependent on the 
Twist box domain. 
(A) Myc-tagged Runx3 with HA-tagged Twist2 or HA-tagged Twist2CΔ 
(Twist box deletion form) was transfected into 293T cells. Cell extracts were 
immunoprecipitated by using anti-HA or IgG antibodies. Western 
hybridization was conducted by using anti-Myc and anti-HA antibodies. (B) 
For Duolink in situ PLA analysis, HeLa cells transfected with the indicated 
expression vectors with anti-Myc/anti-HA followed by the addition of PLA 
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are immunoprecipitated together in Co-IP and red fluorescence signal was 
detected in Duolink assay when Twist2 and Runx3 are overexpressed. 
However, no signal was detected in two experimental systems of Twist2 
carboxyl terminal deletion form and Runx3 overexpression condition. 
Therefore, Twist2 interaction with Runx3 is dependent on Twist2 carboxyl-
terminal Twist-box (Figure 9). Next, I investigated this interaction between 
Twist2 and Runx3 or Cbfβ in distinct thymocyte subsets by using Duolink 
analysis. Importantly, Twist2 and Runx complex interaction was specific only 
in CD8 SP thymocytes and no significant interaction signal could be observed 
in CD8 SP thymocytes from Twist2 cKO mice (Figure 10). Furthermore, this 
interaction was more pronounced in CD4+CD8lo thymocytes from MHC class 
II-/- mice compared with those from B2m-/- mice (Figure 11). These results 
indicated that Twist2 and Runx complex interaction plays distinct roles in the 
critical step of lineage differentiation. It has been reported that the Runx 
complex binds persistently to the RBS1 region of ThPOK in thymocyte subsets, 
regardless of their capability to differentiate into the CD4 or CD8 SP 
lineage(Setoguchi et al., 2008). Thus, it has been postulated that some other 
factor(s) would act to resolve the distinct suppressive activity of the Runx 
complex on ThPOK between CD4 and CD8 SP cells. These results suggest that 
Twist2 interacts with the Runx complex to suppress the expression of ThPOK 










Figure 10. Twist2 interacts with the Runx complex in CD8 SP. 
(A) For Duolink in situ PLA analysis, CD4 SP and CD8 SP thymocytes of 
C57BL/6  and Twist cKO mice were incubated with anti-Twist2 and anti-Cbfβ 
antibodies, followed by the addition of PLA probes. The fluorescence signal 
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Figure 11. Twist2 preferentially interacts with the Runx complex in a CD8 
SP differentiation-specific manner. 
(A) For Duolink in situ PLA analysis, CD4+CD8lo thymocytes of indicated 
mice were incubated with anti-Twist2 and anti-Cbfβ antibodies, followed by 
the addition of PLA probes. The fluorescence signal was measured by confocal 













































Twist2 transgenic mice show a decreased ratio of CD4/CD8 subsets 
and suppressed ThPOK expression 
 
To investigate the function of Twist2, transgenic mice expressing Twist2 under 
the lck-proximal promoter were generated. Intracellular staining assay 
suggested that the ectopic Twist2 expression was slightly increased in DP 
thymocytes, significantly increased in CD4+CD8lo population, and unchanged 
in CD8 SP thymocytes (Figure 12). This suggests that transgenic Twist2 
protein expression conforms to the general lck-proximal promoter pattern. 
Interestingly, the thymi of Twist2 transgenic mice were visibly reduced in size, 
and the total numbers of thymocytes were consistently reduced (Figure 13A). 
The reduced thymic cellularity was accompanied by the increased relative ratio 
of DN thymocytes (Figure 13B), which was considered to be due to impaired 
DN3 to DN4 transition in the Twist2 transgenic mice (Figure 14). In addition, 
the ratio of TCRβ+CD24lo CD4/CD8 SP thymocytes was significantly 
decreased from 2.18 ± 0.08 (mean ± standard error of the mean [SEM]) in non-
transgenic littermate control (NLC) mice to 1.48 ± 0.12 in Twist2 transgenic 
mice (Figure 13C). In the periphery, the number of total splenocytes was 
generally decreased in Twist2 transgenic mice, as for the thymocytes, with a 
consistent decrease in the ratio of CD4/CD8 SP splenocytes (Figure 15).  























Figure 12. In Twist transgenic mice, ectopic Twist2 expression is slightly 
increased in DP thymocytes and is more increased in CD4+CD8lo 
population, but is unchanged in CD8 SP thymocytes. 
Ectopic Twist2 expression was detected by intracellular staining assay using 
anti-Twist2 antibodies.   












Figure 13. Twist2 transgenic mice exhibit a reduced ratio of CD4/CD8 
subsets.  
(A) Numbers of thymocytes from NLC and Twist2 transgenic mice. Each dot 
indicates an individual mouse; the horizontal lines represent the mean with 
SEM. ***P < 0.0001. (B) Thymocyte differentiation profiles based on the 
indicated surface markers from NLC and Twist2 transgenic mice. (C) The ratio 
of TCRβ+CD24lo CD4 SP cells to CD8 SP cells from NLC and Twist2 
transgenic mice. Each symbol indicates an individual mouse; the horizontal 
lines represent the mean with SEM. ***P < 0.0001 (Student’s t-test). 
 
  



















































































Figure 14. Twist2 transgenic mice result in an impaired DN3 to DN4 
transition. 
Thymocytes from Tcra-/- mice and Tcra-/- Twist2 transgenic mice were stained 
with fluorochrome-conjugated anti-CD4, anti-CD8α, anti-CD25, and anti-
CD44 antibodies, and then analyzed by flow cytometry.   
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Figure 15. Twist2 transgenic mice show altered CD4/CD8 differentiation 
profile in splenocytes. 
Splenocytes from NLC and Twist2 transgenic mice were stained anti-CD4, 
anti-CD8α, and anti-TCRb and analyzed by flow cytometry. 
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CD4+CD8lo thymocytes (Figure 16A). When I examined ThPOK expression 
by analyzing the expression of GFP under the control of the ThPOK promoter 
in ThPOK-GFP and Twist2 transgenic mice, the GFP level was significantly 
reduced in CD4+CD8lo thymocytes from ThPOK-GFP and Twist2 transgenic 
mice compared with those from ThPOK-GFP mice(Setoguchi et al., 2008) 
(Figure 16B). The marked change in the GFP level in DN thymocytes was 
mainly due to the lack of mature CD24lo cells (Figure 17). 
 
Enhanced CD4 repression in DP thymocytes by Runx3 and Twist2 
!
!
To investigate the effect of the interaction between Runx3 and Twist2 in 
vivo, I produced mice double transgenic for Runx3 and Twist2, and examined 
their thymocyte differentiation profiles. As Runx3 binds to the silencer regions 
of both CD4 and ThPOK and suppresses the expression of those genes, Runx3 
transgenic mice display biased CD4/CD8 lineage differentiation(Hayashi et al., 
2001; Kohu et al., 2005). In Runx3 and Twist2 double transgenic mice, the DP 
population was more severely reduced compared with NLC and Runx3 
transgenic mice (Figure 18). When TCRβ+CD24lo thymocytes were 
electronically gated, the impairment in CD4 SP development was more 
pronounced in Runx3 and Twist2 double transgenic mice than in Runx3 









Figure 16. ThPOK expression is reduced in Twist2 transgenic mice. 
(A) ThPOK expression was determined by Q-PCR in CD69- DP thymocytes 
and CD4+CD8lo thymocytes from NLC and Twist2 transgenic mice sorted by 
flow cytometry. (B) ThPOK expression was determined by the relative 
fluorescence intensity of GFP from the indicated thymocyte subsets from the 
indicated mice. The numbers above the bracketed lines represent percent GFP-
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Figure 17. Marked decrease in ThPOK-GFP+ DN cells is due to the lack of 
mature CD24lo cells. 
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Figure 18. Analysis of Runx3 and Twist2 transgenic mice by flow 
cytometry. 
CD4 and CD8α expression in total thymocytes (left), TCRβ+ thymocytes 
(middle), and TCRβ+ splenocytes (right) from the NLC, Runx3 transgenic mice, 















































Notably, Twist2 and Runx3 double transgenic mice showed more severe 
reduction in CD4 expression in addition to CD4 SP thymocytes. As the 
expression level of CD4 itself in DP thymocytes can affect the lineage choice, I 
investigated whether Twist2 can modulate CD4 expression, and whether 
continuous expression of CD4 can block the Twist2-induced CD8 SP 
differentiation. 
 Reporter assay with Cd4 promoter, proximal enhancer, silencer, and distal 
enhancer, and ChIP assay suggested that Twist2 could bind to the Cd4 
proximal enhancer and Cd4 silencer, and regulate the Cd4 gene in DP 
thymocytes (data not shown). This raises a possibility that the aberrant 
CD4/CD8 lineage differentiation in Twist2 transgenic mice may result from the 
downregulation of CD4 as observed in Runx3 transgenic mice. Though the 
reduction in CD4 expression in DP thymocytes was observed in the Twist2 
transgenic mouse line presented here, the downregulation was modest. 
Furthermore, the decreased CD4/CD8 SP ratio was also observed in another 
Twist2 transgenic line without any significant change in CD4 level (data not 
shown). In Twist2-transfected thymoma cell lines, ThPOK could be 
downregulated regardless of TCR stimuli (Figure 6).  
In Twist2 and CD4 double transgenic mice, the electronically gated 
TCRβ+CD24lo cells showed similar decrease in CD4/CD8 SP ratio to those 
from Twist2 transgenic mice (Figure 19). Also, I tested whether Twist2 can 
affect MHC class II-restricted cells with constitutive CD4 transgene. CD4 
transgenic systems of B2m-/- or MHC class II-restricted TCR transgenic mice 










Figure 19. In Twist2 and CD4 double transgenic mice, the electronically 
gated TCRβ+CD24lo cells show similar decrease in CD4/CD8 SP ratio to 
those from Twist2 transgenic mice. 
(A) Thymocyte differentiation profiles based on the CD4, CD8, TCRβ, 
and CD24 surface markers from CD4 tansgenic mice and CD4 and Twist2 
double transgenic mice. (B) The ratio of TCRβ+CD24lo CD4/CD8 SP cells 


















Likewise, OT2-TCR and CD4 double transgenic mice have mature 
CD4+CD8+ cells. In this system, OT2-TCR, Twist2 and CD4 triple transgenic 
mice have an even greater number of CD4+CD8+ cells (Figure 20).  Therefore, 
the reduction of mature CD4 SP cells in Twist2 transgenic mice is not likely to 
be caused by the decreased CD4 expression during DP development, but by the 
Twist2 acting directly to drive the CD8 SP lineage.  
 
Altered CD4/CD8 SP thymocyte differentiation in Twist2 conditional 
knock out mice 
!
As Twist2 knock out mice show perinatal death and systemic elevation of 
various cytokines that affect thymocyte development and differentiation(Sosic 
et al., 2003), I used a Twist2 conditional knock out (cKO) mouse system to 
investigate the effect of loss-of-function of Twist2 during thymocyte 
differentiation. The CD4-specific deletion of Twist2 showed a slight decrease 
in total thymic cellularity (Figure 21A). Compared with CD4-Cre Twist2+/+ 
mice, CD4-Cre Twist2f/f mice showed altered CD4 and CD8 SP differentiation 
profiles with a decreased percentage of TCRβ+CD24lo thymocytes (Figure 
21B). In addition, the ratio of TCRβ+CD24lo CD4 SP to CD8 SP thymocytes 
was significantly increased from 2.06 ± 0.132 in CD4-Cre Twist2+/+ mice to 
3.14 ± 0.174 in CD4-Cre Twist2f/f mice, which is thought to result from 











Figure 20. Mature CD4+CD8+ cells with cytotoxic function are increased in 
OT2-TCR, CD4 and Twist2 triple transgenic mice compared to the 
controls. 
 (A) Flow cytometry analysis of CD4, CD8α, CD24 and Vα2 expression on 
thymocytes from the indicated mice. (B) Q-PCR analysis of RNA purified 

















Figure 21. Thymocyte-specific Twist2 deficiency is associated with an 
increased ratio of CD4/CD8 subsets. 
(A) Numbers of thymocytes from CD4-Cre Twist2+/+, CD4-Cre Twist2f/+ and 
CD4-Cre Twist2f/f mice. Each symbol indicates an individual mouse; the 
horizontal lines represent the mean with SEM. *P = 0.0180 (Student’s t-test). 
(B) Thymocyte differentiation profiles based on the indicated surface markers 
from the indicated mice. (C) The ratio of TCRβ+CD24lo CD4/CD8 SP cells 
from the indicated mice. Each symbol indicates an individual mouse; the 
horizontal lines represent the mean with SEM. **P = 0.0021 (Student’s t-test). 
(D) Cell numbers of CD4 SP and CD8 SP from CD4-Cre Twist2+/+ and CD4-











































































































While Twist2 transgenic mice showed significantly reduced ThPOK 
expression in CD4+CD8lo thymocytes, Twist2 cKO mice showed increased 
ThPOK expression in the same population (Figure 22). There was also a slight 
increase in ThPOK expression in CD8 SP thymocytes. In addition, the lck-
dependent deletion of Twist2 increased the number of TCRβ+CD24lo CD4 SP 
thymocytes in Runx3 transgenic mice (Figure 23). 
 
Altered CD4/CD8 SP thymocyte differentiation in Twist2 transgenic 
mice and Twist2 cKO mice expressing transgenic TCR 
 
 
  On the basis of the differential expression of Twist2 during CD4 and CD8 SP 
thymocyte differentiation in vitro, and the altered CD4/CD8 SP thymocyte 
ratio in Twist2 transgenic mice, I further investigated the effect of Twist2 in 
TCR transgenic mice. As DO-TCR is restricted to MHC class II molecules, 
these transgenic mice preferentially generate CD4 SP cells(Hogquist et al., 
1994). In Rag-/- DO-TCR and Twist2 double transgenic mice, the percentage 
and the cell number of the CD4 SP population was significantly decreased, 
whereas the percentage and the cell number of the CD8 SP population was 
increased, resulting in a decreased relative DO+CD24lo CD4/CD8 SP 
thymocyte ratio (Figure 24). In splenocytes, Rag-/- DO-TCR and Twist2 double 
transgenic mice showed a consistent decrease in the CD4 SP population and an 










Figure 22. ThPOK expression is increased in Twist2 conditional knock out 
mice. 
ThPOK expression was determined by the relative fluorescence intensity of 
GFP from the indicated thymocyte subsets from the indicated mice. The 































Figure 23. lck-dependent deletion of Twist2 increased the number of 
TCRβ+CD24lo CD4 SP thymocytes in Runx3 transgenic mice. 
CD4 and CD8α expression in total thymocytes and TCRβ+CD24lo thymocytes 














































Figure 24. In Rag-/- DO-TCR and Twist2 double transgenic mice, the 
percentage and the cell number of the CD4 SP population is significantly 
decreased, whereas the percentage and the cell number of the CD8 SP 
population is increased. 
 (A) CD4 and CD8α expression in total thymocytes, DO+CD24lo thymocytes, 
and splenocytes from Rag-/- DO-TCR transgenic mice and Rag-/- DO-TCR 
Twist2 transgenic mice. (B) Frequency and cell number of mature CD4 SP and 
CD8 SP thymocytes in Rag-/- DO-TCR transgenic mice and Rag-/- DO-TCR 
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splenocytes have CD8αβ heterodimer phenotype (Figure 25). Conversely, 
when Twist2 transgenic mice were crossed with Rag-/- HY-TCR transgenic 
mice, in which transgenic TCR is restricted to MHC class I 
molecules(Kisielow et al., 1988), differentiation into the CD8 SP population 
was further enhanced in Rag-/- HY-TCR and Twist2 double transgenic mice 
(Figure 26A and 26B).!
 To further investigate the loss of Twist2 function during thymocyte 
differentiation, I generated Twist2 cKO mice under various TCR transgenic 
backgrounds. Interestingly, CD8 SP differentiation was significantly perturbed 
in Rag-/- HY-TCR CD4-Cre Twist2f/f mice, where overall thymocyte cellularity 
was reduced, and consequently there was a significant reduction in mature CD8 
SP cells (Figures 27A and 27B). In contrast, CD4 SP thymocytes were slightly 
increased in the MHC class II-restricted TCR-transgenic background (Figure 
28). Rag-/- DO-TCR CD4-Cre Twist2f/f mice showed increased numbers of DO+ 
thymocytes compared with Rag-/- DO-TCR CD4-Cre Twist2+/+ control mice, 
and DO+ CD4 SP thymocytes were also slightly increased.  
 
Lineage conversion in Twist2 transgenic and Twist2 cKO mice 
 
On the basis of the finding that Twist2 produced MHC class II-restricted CD8 
SP cells in Rag-/- DO-TCR transgenic mice, I next tested whether Twist2 can 











Figure 25. CD4lowCD8+ mature thymocytes and splenocytes in Rag-/- DO-
TCR and Twist2 double transgenic mice express CD8αβ heterodimers.  
(A) Expression of CD4, CD8α and CD8β by mature DO+CD24lo thymocytes 
from the indicated mice. (B) Expression of CD4, CD8α and CD8β by 

















Figure 26. Differentiation into the CD8 SP population is further enhanced 
in Rag-/- HY-TCR and Twist2 double transgenic mice compared with Rag-/- 
HY-TCR mice. 
(A) CD4 and CD8α expression in total thymocytes, HY+CD24lo thymocytes 
and splenocytes from Rag-/- HY-TCR transgenic mice and Rag-/- HY-TCR 
Twist2 transgenic mice. (B) Frequency of mature CD4 SP and CD8 SP 
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Figure 27. CD8 SP differentiation is significantly perturbed in Rag-/- HY-
TCR CD4-Cre Twist2f/f mice compared with control mice. 
(A) CD4 and CD8α expression in total thymocytes and HY+CD24lo thymocytes 
from Rag-/- HY-TCR CD4-Cre Twist2+/+ mice and Rag-/- HY-TCR CD4-Cre 
Twist2f/f mice. (B) Frequency and cell number of mature CD4 SP and CD8 SP 
thymocytes in Rag-/- HY-TCR CD4-Cre Twist2+/+ mice and Rag-/- HY-TCR 
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Figure 28. CD4 SP thymocytes were slightly increased in Twist2 cKO mice 
with MHC class II-restricted TCR-transgenic background. 
(A) CD4 and CD8α expression in total thymocytes and DO+CD24lo thymocytes 
from Rag-/- DO-TCR CD4-Cre Twist2+/+ mice and Rag-/- DO-TCR CD4-Cre 













mice, B2m-/- Twist2 transgenic mice generated significant numbers of CD8 SP 
cells in the thymus (Figure 29). Concurrently, the percentage of TCRβ+ CD4 
SP thymocytes was significantly decreased in B2m-/- Twist2 transgenic mice. In 
the periphery, B2m-/- Twist2 transgenic mice displayed significant numbers of 
CD8 SP splenocytes.  
 I also analyzed the effect of Twist2 deficiency on CD4/CD8 lineage 
differentiation under MHC class II-deficient background. The overall thymic 
cellularity was decreased in MHC class II-/- CD4-Cre Twist2f/f mice compared 
with MHC class II-/- CD4-Cre Twist2+/+ mice, and there was a significant 
reduction in the numbers of TCRβ+CD24lo CD8 SP thymocytes in Twist2 cKO 
mice (Figure 30). It is also clear that CD8 SP differentiation is severely 
affected when splenocytes were analyzed. However, there was only minor, and 
no significant, change in CD4 SP cells in MHC class I-restricted thymocytes 
from Twist2 cKO mice.  
In addition, I carried out bone marrow transplantation of Twist2 cKO mice 
into MHC class II-/- mice. Lethally irradiated (1,100 rad) MHC class II-/- 
recipients were reconstituted with 1:1 mixture of T-cell depleted bone marrow 
from congenic CD45.1+ mice and from either CD45.2+ lck-Cre Twist2+/+ or lck-
Cre Twist2f/f mice. Similarly to MHC class II-/- CD4-Cre Twist2f/f mice, only 
minor, and no significant, increase in CD4 SP thymocytes was observed 









Figure 29. B2m-/- Twist2 transgenic mice generated significant numbers of 
CD8 SP cells in the thymus. 
Thymocyte differentiation profiles based on CD4 and CD8α expression and 
TCRβ expression of total thymocytes, and CD4 and CD8α expression of 










Figure 30. The numbers of TCRβ+CD24lo CD8 SP thymocytes was reduced 
in MHC class II-/- CD4-Cre Twist2f/f mice compared with MHC class II-/- 
CD4-Cre Twist2+/+ mice. 
(A) Thymocyte differentiation profiles based on the indicated surface markers 
from the MHC class II-/- CD4-Cre Twist2f/f mice and control mice. (B) Cell 















Figure 31. Bone marrow transplantation of Twist2 cKO mice into MHC 
class II-/- mice. 
CD45.1 and CD45.2 expression (above) on thymocytes from irradiated MHC 
class II-/- recipients of lck-Cre Twist2+/+ (left) or lck-Cre Twist2f/f (right) 
CD45.2+ bone marrow mixed at a ratio of 1:1 with wild-type (CD45.1+) bone 
marrow. TCRβ+CD24lo CD4/CD8 SP cells from each CD45.1+ and CD45.2+ 











To test how efficiently CD4 SP thymocytes generated compared with MHC 
class II-/- CD4-Cre Twist2f/f, I analyzed Runx3-, Mazr-, or CBFb-conditional 
knock out mice with MHC II -/- background. CD4/CD8 profile is similar 
between MHC class II-/- CD4-Cre Mazrf/f and MHC class II-/- CD4-Cre Twist2f/f 
(Figure 32).  As reported, Runx3- and CBFb-conditional knock out mice 
showed CD4 derepression, so mature DP (TCRbhigh,CD24lo, CD4+CD8+) cells 
appeared.  Also, CBFb-conditional knock out mice showed significant increase 
of CD4+ thymocytes. To confirm whether generated CD4+ cells and mature DP 
cells are functionally CD4 SP or not, these cells were sorted and checked for 
the ThPOK and perforin mRNA level. As a result, ThPOK expression level is 
low and perforin level is high in both CD4+ cells and mature DP cells (Figure 
33). Therefore, CD4+ cells in Runx- or CBFb-conditional knock out mice are 
merely phenotypical CD4+ that are not functional CD4 SP cells.     
As it was reported that Twist1 and Twist2 exert similar functions in 
various tissues, I investigated the possible redundancy of Twist proteins in 
CD4/CD8 lineage differentiation. In contrast to Twist2 cKO mice, Twist1 cKO 
mice showed no significant changes in thymocyte differentiation profile. There 
was no significant effect on ThPOK expression, and no interaction with Runx 
complex (Figure 34). Twist1 and Twist2 double cKO mice showed similar 











Figure 32. Analysis of Twist2-, Mazr -, Runx3-, and CBFb-deficient mice 
with MHC class II-/- background. 
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Figure 33. CD4+ cells in Runx-conditional knock out mice are merely 
phenotypical CD4+ that are not functional CD4SP cells.     
ThPOK and Perforin1 expression was determined by Q-PCR in CD4+ 
thymocytes and mature DP (TCRbhighCD24loCD4+CD8+) thymocytes from 



























































































































Figure 34. Thymocyte-specific Twist1 deficiency is not associated with 
CD4/CD8 lineage differentiation. 
(A) Thymocyte differentiation profiles based on the indicated surface markers 
from the indicated mice. (B) ThPOK expression was determined by the relative 
fluorescence intensity of GFP from the indicated thymocyte subsets from the 
indicated mice. (C) For Duolink in situ PLA analysis, the indicated subsets of 
WT thymocytes were incubated with anti-Twist1 and anti-Cbfβ antibodies, 
followed by the addition of PLA probes. The fluorescence signal was measured 








       CD4/CD8 T cell lineage commitment is key issues in the development of 
the immune system. Several transcription factors are known to participate 
during CD4/CD8 lineage commitment. Particularly, ThPOK seems to be both 
necessary and sufficient for CD4-lineage differentiation and Runx3 plays an 
important role in CD8 SP differentiation by repressing ThPOK expression. 
However, Runx complex binds persistently to the silencer region of ThPOK in 
thymocyte subsets, regardless of their capability to differentiate into the CD4 
or CD8 SP lineage. Thus, some other factor would act to resolve the distinct 
suppressive activity of the Runx complex on ThPOK between CD4 and CD8 
SP cells. Here, I showed that Twist2 expression is finely regulated during 
thymocyte development and differentiation, and it plays a critical role during 
CD4/CD8 lineage differentiation by controlling ThPOK expression through its 
interaction with the Runx complex. 
 
Twist2 expression is differentially regulated by T-cell receptor signaling 
leading to differentiation into the CD4 or CD8 lineage 
 
Transcription factor Twist2 is tightly regulated during thymocyte 
development in a differentiation stage-specific manner. Twist2 is upregulated 
at the CD4+CD8lo stage when thymocytes undergo positive selection through 
TCR-MHC engagement. Interestingly, Twist2 upregulation was negatively 
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correlated with the intensity of the activation signal, i.e., a weak activation 
signal for CD8 SP differentiation induced much higher activation of Twist2 
expression than a strong signal for CD4 SP differentiation (Figure 35). 
Consistently, Twist2 expression was differentially regulated when thymocytes 
differentiated into CD4 or CD8 SP cells. Twist2 expression was higher in CD8 
SP thymocytes than in CD4 SP thymocytes. These results suggest that Twist2 
is directly regulated by TCR signaling, which is crucial for thymocyte selection 
and lineage differentiation processes. 
 
Twist2 is involved in CD4/CD8 thymocyte lineage determination by 
regulating a crucial transcription factor, ThPOK, through its interaction with 
another important factor, the Runx complex.  
 
Recent studies have revealed that various transcription factors are involved 
in CD4/CD8 lineage commitment(He et al., 2005; Hernandez-Hoyos et al., 
2003; Pai et al., 2003; Sakaguchi et al., 2010; Setoguchi et al., 2008; Sun et al., 
2005a, b; Wilkinson et al., 2002; Woolf et al., 2003). Among them, ThPOK is 
a crucial factor for CD4 SP differentiation, and its expression is mainly 
regulated by Runx complexes. However, persistent binding of Runx complexes 
to the silencer region of the ThPOK promoter, regardless of the differentiation 
stage, raised the possible involvement of other factor(s) in the regulation of 
ThPOK expression. Twist2 was previously shown to interact with Runx1 and 
Runx2, and its interaction with Runx3 was also reported recently(Pham et al., 
2012; Sharabi et al., 2008; Yang et al., 2011). I demonstrated that Twist2 
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interacts with Runx3 by Co-IP and Duolink assay, and that the interaction 
between Twist2 and the Runx complex is stage-specific by using the Duolink 
assay. Furthermore, a ChIP assay suggested that Twist2 could bind to the 
silencer region of the ThPOK promoter in a lineage-dependent manner. Biotin 
pull-down assay using biotinylated oligomers corresponding to NF-κB / E box 
region and Runx binding region of ThPOK silencer showed that Twist2 was 
specifically bound to the Runx binding sites. It appears that there is a 
difference between the interaction of Twist2 with Runx during CD4 and CD8 
lineage differentiation (Figure 35). Previous reports have shown that Twist2 
interacts with Runx proteins, and thereby inhibits their transcriptional 
activity(Sharabi et al., 2008; Yang et al., 2011). In addition, Twist2 expression 
was associated with the transcriptional downregulation of Runx genes(Sharabi 
et al., 2008). However, Twist2 did not suppress the expression of Runx3 (data 
not shown) in this system. Moreover, like Runx3, Twist2 downregulated the 
expression of ThPOK in vitro and in vivo (Figure 6 and Figure 13), and a 
ChIP assay showed that Twist2 binds only to the silencer region among the two 
major Runx targets. These results suggest that the Twist2 and Runx complex 
interaction in this system resulted in the cooperative suppression of ThPOK. 
This kind of cooperation between Twist2 and Runx3 was also suggested by 
results obtained from the Twist2 and Runx3 double transgenic mice, in which 
CD4 expression was much more severely affected (Figure 18). This 
cooperative regulation by Twist2 and Runx3 may not be limited to ThPOK but 
may be extended to Cd4 and other targets on which Runx3 acts as a repressor.  
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Twist2 was associated with altered CD4/CD8 thymocyte lineage 
differentiation 
 
 The ratio of TCRβ+CD24lo CD4/CD8 SP thymocytes was significantly 
decreased in Twist2 transgenic mice, whereas the ratio was significantly 
increased in Twist2 cKO mice (Figures 13C and 21C). In MHC class II-
restricted TCR transgenic mice, Twist2 impaired TCR-transgenic CD4 SP 
development, whereas significant numbers of MHC class II-restricted CD8 SP 
thymocytes and splenocytes were generated (Figure 24). In contrast, the 
development of CD8 SP thymocytes expressing MHC class I-restricted TCR 
was significantly impaired by Twist2 deficiency (Figure 26). Further 
investigation with B2m-/- mice demonstrated that Twist2 could generate MHC 
class II-restricted CD8 SP cells (Figure 29). As I can rule out any effects of 
endogenous TCRs in TCR transgenic mice, this result can be interpreted as 
lineage conversion. The lineage conversion was closely related with the 
differential binding of Twist2 to the Runx complex and RBS1 region of 
ThPOK in CD4+CD8lo thymocytes, resulting in the distinct expression of 
ThPOK in these thymocytes.  
 
The enforced expression of Twist2 converts MHC class II-restricted cells to 




It has been reported previously that Runx3 binds to the silencer regions of 
both CD4 and ThPOK and suppresses the expression of those genes and Runx3 
transgenic mice exhibit substantial redirection of MHC class II-restricted 
thymocytes into the CD8 lineage, but this effect can be corrected with a CD4 
transgene, indicating that it is an indirect consequence of CD4 
downmodulation (or additional effects on ThPOK expression). Because if CD4 
expression is suppressed in DP thymocytes, chance of MHC class II-CD4 
interaction is decreased, leading to perturbed CD4 SP differentiation. To check 
the possibility that the aberrant CD4/CD8 lineage differentiation in Twist2 
transgenic mice may result from the downregulation of CD4 as observed in 
Runx3 transgenic mice. Twist2 is likely to suppress CD4 expression in DP 
thymocytes. This was observed in a line of Twist2 transgenic mice (provided in 
the Figures). After I observed decreased CD4 expression in Twist2-transfected 
thymoma cell lines and Twist2 transgenic mice, I tested whether Twist2 can 
bind CD4 cis-elements, including promoter, proximal enhancer, silencer and 
distal enhancer using ChIP assay. The results suggested that Twist2 may be 
associated with proximal enhancer and silencer regions (data not shown). 
However, I focus more on Twist2-mediated ThPOK repression because  
1) CD4 downregulation was modest in Twist2 transgenic mice and another line 
of Twist2 transgenic mice showed a similar CD4/CD8 SP differentiation 
pattern with no significant change in CD4 expression  
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2) ThPOK is regulated by Twist2 and supported by results that ThPOK was 
downregulated in Twist2-transfected thymoma cell lines regardless of TCR 
stimuli and Twist2 conditional knock out results.  
3) Furthermore, I investigated the thymocyte differentiation profile of Twist2 
and CD4 double transgenic mice. The electronically gated TCRβhiCD24lo cells 
from Twist2 and CD4 double transgenic mice showed a similar decrease in 
CD4/CD8 SP ratio to those in Twist2 transgenic mice (Figure 19).  
4) Also, I have analyzed OT2-TCR, Twist2 and CD4 Triple transgenic mice 
whether Twist2 can affect MHC class II-restricted cells with constitutive CD4 
transgene. OT2-TCR transgenic mice had few CD8+ cells (<3%) but OT2-TCR 
and CD4 double transgenic mice had far increased mature CD4+CD8+ cells (i.e. 
CD8 SP) (25~35%). These results are quite similar to the ones reported in ref. 
(Davis et al., 1993), where mature CD4+CD8+ cells with cytotoxic function 
were observed in B2m-/- or PCC TCR Tg mice with CD4 overexpression, OT2-
TCR and CD4 double transgenic mice also showed mature CD4+CD8+ cells. 
Analysis of OT2-TCR, CD4 and Twist2 triple transgenic mice confirmed that 
mature CD4+CD8+ T cells increased greatly compared to the controls (Figure 
20).  
 These results support that the enforced expression of Twist2 converts MHC 
class II-restricted cells to CD8 SP cells by direct repression of ThPOK 
expression, rather than by CD4 repression. Therefore, I concluded that the 
Twist2 transgenic mice phenotype is not a secondary effect of CD4 repression 
but a consequence of Twist2 redirecting CD4 T cells into the CD8 lineage.  
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Possible reasons why Twist2 deficiency could not efficiently generate MHC 
class I-restricted CD4 SP cells 
 
As for the loss-of-function of Twist2, the CD4/CD8 SP ratio was increased 
in Twist2 cKO mice. The increased CD4/CD8 SP ratio can be caused by 
increase in CD4 SP cells, decrease in CD8 SP cells, or both. When slightly 
lower thymic cellularity and decreased TCRβ+CD24lo population in Twist2 
cKO mice are taken into consideration, It is apparent that the cell numbers of 
CD8 SP cells are much more severely decreased (p<0.01), while the decrease 
in CD4 SP cell numbers is not statistically significant (Figures 21B and 21D). 
Similar results could be obtained in Rag-/- HY-TCR transgenic Twist2 cKO 
mice, and MHC II-/- Twist2 cKO mice (Figures 26B and 30B). These results 
raised the possible involvement of Twist2 in lineage conversion, but Twist2 
deficiency could not efficiently generate MHC class I-restricted CD4 SP cells 
under MHC class II-deficient background (Figure 30). I think there are three 
possibilities to explain this inefficient redirection.  
Since Twist2 acts as a repressor, ThPOK repression by Twist2 is more 
apparent in Twist2 transgenic mice. However, in Twist2 cKO mice, this 
repression appears to be released, increasing ThPOK expression, though to a 
modest degree. It was reported that there is a threshold of ThPOK expression  
that is required for complete commitment to the CD4+ lineage(Muroi et al., 
2008). I think the presence of repressors combined with the near absence of 
activators leads to low levels of ThPOK expression in CD4+CD8lo thymocytes 
of CD8 differentiation condition (MHC II KO or CD8 SP derived TCR Tg), so 
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ThPOK expression did not reach the threshold. Since thymocytes of MHC II 
knock out mice are cells signaled to become CD8 SP, a factor required to 
induce ThPOK may not be present in these cells, resulting in only modest 
induction of ThPOK due to absence of Twist2 and thus poor conversion into 
CD4 lineage cells. 
I would like to suggest another explanation to the minor redirection in 
MHC II and Twist2 double knock out mice. ThPOK silencer has two important 
regions, which are an essential 80bp core sequence (containing NFkb and E 
box) and a Runx binding domain.  He et al. (2008) showed that ThPOK was 
not fully derepressed with only E box mutation or only Runx binding domain 
deletion. Only DRE (or RBS1) deletion or simultaneous deletion of both E box 
and Runx binding domain induced ThPOK derepression. Therefore, I think 
both sites (E box domain and Runx binding domain) are necessary for silencer 
activity. Runx3 binds to Runx binding domain in the RBS1 region, after which 
Twist2 interacts with Runx3, while unknown proteins bind to NFkB and E box 
region of RBS1. This combination can suppress the ThPOK expression, so 
deletion of each protein did not show a dramatic effect because suppression at 
the other site remains intact. Therefore, I think that derepression effect will 
become clear when protein interaction at both sites are disrupted.  
Lastly, it is possible that epigenetic modification may have already 
occurred in CD4+CD8lo cells of MHC II-/- mice. Tanaka et al. (2013) checked  
modification of histone H3 lysine residues of ThPOK locus, especially 
H3K4me3 and H3K27me3 that mark active and repressive states, 
respectively(Tanaka et al., 2013). In CD4 SP, active H3K4me3 deposition was 
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detected in silencer, promoter, and proximal enhancer regions but repressive 
H3K27me3 was almost not detected. On the other hand, in CD8 SP, repressive 
H3K27me3 was highly detected in silencer region but H3K4me3 signal was 
not detected. Muroi et al. (2008) showed ThPOK expression patterns in 
CD4+CD8lo cells in several mice. ThPOK expression was increased about two-
fold in B2m-/- mice and decreased to about 1/10 in MHC II-/- mice compared 
with WT mice. Also, although Runx complex and MAZR are well known 
regulators of ThPOK expression and CD4/CD8 lineage commitment, MHC 
class-I restricted CD4 SP cells are actually not efficiently generated in 
Runx1/Runx3 double cKO mice and MAZR KO mice, as in Twist2 cKO mice 
(Figures 32 and 33). These results imply that epigenetic modification (low 
active marks and high repressive marks) of silencer region has already 
occurred in CD4+CD8lo in MHC II-/- mice, so repressor proteins do not need to 
bind and suppress the ThPOK expression. Also, proximal enhancer may have 
low amount of active H3K4me3 in CD4+CD8lo in MHC II-/- mice, so it is hard 
to fully increase the ThPOK expression. Therefore, I think that ThPOK 
expression increase modest and MHC class-I restricted CD4 SP is not 
efficiently generated in MHC II-/- background mice. 
 
Twist1 deficiency is not associated with CD4/ CD8 lineage differentiation 
 
  Twist1 and Twist2 proteins share high structural homology. Both contain 
a basic helix-loop-helix DNA binding domain, and can form homodimers or  
! 98!
heterodimers with another bHLH protein through this domain(Li et al., 1995; 
Sosic et al., 2003). Moreover, Twist proteins share the Twist box in the C-
terminus, which is important for interaction with other proteins including Runx 
proteins. In an attempt to investigate the redundant roles of Twist proteins 
during CD4/CD8 lineage differentiation, I analyzed Twist1 cKO and Twist1 
and Twist2 double cKO mice. I found no evident role of Twist1 during the 
differentiation in view of thymocyte differentiation profile, ThPOK expression, 
and interaction with Runx complex (Figure 34). Based on these findings, it 
appears that there is no functional redundancy between Twist1 and Twist2 at 
least during the CD4/CD8 thymocyte lineage differentiation. 
 
Potential additional role of Twist2 that interacts with transcriptional 
factors that are significantly implicated in CD4/CD8 lineage differentiation 
 
In view of the transcription factor network that governs the CD4/CD8 
lineage differentiation of DP thymocytes, Twist2 may serve as an early player 
during lineage specification based on its TCR signaling-dependent regulation. 
Twist2 may regulate the expression of ThPOK also through the regulation of 
other upstream factors in addition to its direct activity on the silencer region of 
the ThPOK promoter. ThPOK expression was shown to be dependent on Gata3, 
and Gata3 is regulated by c-Myb(Maurice et al., 2007; Wang et al., 2008). 
Although I found that Twist2 could downregulate Gata3 to some extent in vitro 
(Figure 6), the precise regulatory mechanisms remain to be identified. 
Recently, it was reported that E proteins are required for the development of  
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CD4 lineage T cells; persistent E protein activity during positive selection may 
permit CD4 lineage development while preventing CD8 lineage 
development(Jones-Mason et al., 2012). Twist2 was shown to form a 
heterodimer with E proteins and also interact with the NF-κB transcription 
factor(Sosic et al., 2003). Although Twist2 did not bind to NK-κB or the E box 
fragment of the silencer region of ThPOK (Figure 8A), it is possible that 
Twist2 is involved in the E-protein-dependent regulation of Gata3.  
 
In summary, my results demonstrate that Twist2 is activated by TCR 
signaling, and its lineage-specific expression pattern and interaction with the 
Runx complex are involved in the regulation of ThPOK expression during 
CD4/CD8 lineage differentiation. The gain-of-function and loss-of-function 
mutations in Twist2 showed its critical role in CD4/CD8 SP lineage 
differentiation. The identification of Twist2 as a novel key player in CD4/CD8 
T cell lineage differentiation provides another important clue to understanding 
the molecular mechanism underlying the differentiation of thymocytes into 
CD4/CD8 lineage SP cells. Furthermore, my results clearly offer the answer to 
the key question of how Runx represses the expression of ThPOK. Runx 
complex is bound to both the silencer and the enhancer region of ThPOK 
throughout T cell differentiation. Thus the differential regulation of ThPOK 
expression in CD4/CD8 lineage differentiation could not be explained by Runx 
alone. My data provide critical evidence of Twist2 as a new factor that is 
regulated by TCR signaling strength and in turn directly represses the 
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국 4 초 록 
 
CD4/CD8 T 세포 계열 결정 과정에서 
Twist2 의 기2 8/ 
 
황 선 숙 
 
  ./4/./8 T 세포 계열 결정은 면역시스템 발p에 중요하n. T.: 신호의 
강t와 지속시T이 ./4/./8 계열을 결정하l 중요 인자로 알려져 있n. 
또한 ./4/./8 T 세포 계열 결정에 b여하l 여러가지 전사인자들이 
밝혀져있n. 2aLa3 와 TBP84 은 ./4 T 세포로 분화하ls 중요하n고 
알려져 있l 반면, :MGO3 와 MaPr l ./8 T 세포로 분화하ls 중요한 
역할을 한n고 알려져 있n. 특히 TBP84 o백질의 발현은 ./4 T 세포로 
분화하ls 필요 충분조건으로 여겨지고, :MGO3 l TBP84 발현의 억제를 
통해 ./8 T 세포로 분화하ls 역할을 한nl 사실이 잘 알려져 있n. :MGO 
o백질은 TBP84 의 KCEeGcer 부위에 결합하고 있ls,  ./4 T 세포i ./8 T 
세포에 b계없이 항상 결합u어 있음이 알려져있n. 이러한 g존의 연c들은 
지금h지 보고u지 않은 새로운 인자가 ./4 T 세포와 ./8 T 세포에서 
n르게 TBP84 의 KCEeGcer 에 결합하여 :MGO 의 억제 활성을 조절 할 
가m성을 제시하고 있n.  
  TNCKL2 l b3L3 전사인자로서 주로 전사 억제자로 작용함이 알려져있n. 
최e TNCKL2 l T.: 신호에 의해 d 발현이 조절u며 흉선세포의 생존a 
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죽음에 b여함이 보고u었n. 특히 7Mr77 a 7Hr-1 의 발현을 조절하여 
‘T.: 신호-매개 세포사멸R을 조절한nl 것이 잘 알려져 있n. 이러한 
결a들은 TNCKL2 가 흉선세포 발생a정에 중요한 역할을 할 것이라l 것을 
예상해 볼 수 있게 한n.   
         이 논문은 TNCKL2 가 ./4/./8 계열 결정에서 중요하nl 것을 밝히고 있n. 
TNCKL2 l T.: 신호에 의해서 d 발현이 유tu며, 특히 ./4 T 세포와 ./8 
T 세포로 가l T.: 신호에 z라 d 발현 정t가 p라진n. ./8 T 세포로 
가l 신호가 왔을 때 r 많이 발현u며, 오래 지속된n. 또한 TNCKL2 의 발현은 
./4 T 세포에서보n ./8 T 세포에서 kn. d리고 TNCKL2 l :MGO3 와 
결합할 수 있고, 이 결합은 TNCKL2 o백질의 .-말o 부위인 TNCKL2 bHO 
부분을 통해서 이루어진n. 또한 TNCKL2 o백질은 :MGO3 와 마찬가지로 
TBP84 의 KCEeGcer 부위에 결합하여 TBP84 의 발현을 억제한n. :MGO 와의 
차이점은 :MGO o백질은 TBP84 의 KCEeGcer 에 항상 붙어있l 반면, 
TNCKL2 l ./8 T 세포 특이적으로 결합한nl 것이n. TBP84 의 KCEeGcer 
부위l w가지 중요부위가 알려져 있ls, 71-D- 와 0 bHO 를 포함하l  
필수적인 80bp 의 핵심 서열a :MGO 복합체가 결합할 수 있l :MGO bCGdCGg 
dHFaCG 이 있n. TNCKL2 l 특이적으로 :MGO bCGdGg dHFaCG 에 결합하l 
것을 확인하였n. 이 결a들은 TNCKL2 가 ./8 계열 특이적으로 TBP84 의 
KCEeGcer 부위 중 :MGO 가 붙어있l 곳에 결합하여 TBP84 의 발현을 
억제한nl 사실은 말해준n. r욱이 TNCKL2 a발현 마우스l ./4 T 세포의 
생성이 감소하고, ./8 T 세포의 생성이 증가u어 있n. 또한  ./4 T 세포만 
생성u고 ./8 T 세포가 생성u지 않l B2m
-/-  마우스에서 조차 TNCKL2 가 
a발현된 경우 ./8 T 세포가 생성된 것을 알 수 있n. 반대로 TNCKL2 
결핍마우스의 경우에l ./8 T 세포로 분화가 유tul T.: 마우스에서 
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조차 ./8 T 세포의 생성이 줄어xl 것을 확인할 수 있n. 이 논문은 유전자 
a발현 마우스 시스템a 유전자 결핍 마우스 시스템을 이용하여 TNCKL2 가 
./8 T 세포 발생 특이적으로 :MGO 와의 결합을 통해  TBP84 의 KCEeGcer 
부위에 결합하여 TBP84 의 발현을 억제함으로써 ./4/./8 계열 결정에 
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